• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

7.622 -0.198 (-2.53%)
Streaming Delayed Price Updated: 3:52 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2 3 4 Next >
News headline image
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
January 07, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
January 06, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
December 09, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Two Investor Conferences in December
November 20, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
November 05, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months
November 04, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
October 29, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
October 28, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Design Therapeutics Appoints Justin Gover to Board of Directors
September 10, 2025
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
September 02, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Four Investor Conferences in September
August 27, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
August 05, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights
July 31, 2025
From Compass Pathfinder
Via Business Wire
News headline image
Compass Pathways Appoints Justin Gover to Board of Directors
July 29, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025
July 22, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET
July 10, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
June 23, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
From FN Media Group LLC
Via GlobeNewswire
News headline image
Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
May 14, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
May 08, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
April 29, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
April 28, 2025
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
April 22, 2025
From Compass Pathways plc
Via Business Wire
News headline image
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
March 26, 2025
From Compass Pathways plc
Via Business Wire
More People are Microdosing Psychedelics to Ease the Challenges of Parenting
March 24, 2025
Via Investor Brand Network
News headline image
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
March 18, 2025
From Compass Pathways plc
Via Business Wire
News headline image
Compass Pathways to Participate in Stifel Virtual CNS Forum
March 11, 2025
From Compass Pathways plc
Via Business Wire
US Embassy Tells Americans to Desist from Using Ayahuasca in Peru
March 10, 2025
Via Investor Brand Network
Topics Law Enforcement
News headline image
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
February 27, 2025
From Compass Pathways plc
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap